Active surveillance could apply to one-quarter of Korean prostate cancer cases: Insights from a 27,075-patient cohort
Prostate International · 2026-06 · 14 (2) · 127-131
DOI: 10.1016/j.prnil.2025.12.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prostate International, 2026-06. Verfasst von Young Hwii Ko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, College of Medicine, Ewha Womans University, Mokdong Hospital, Seoul, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and ICT, South Korea, Korea Health Industry Development Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
Background
The aims of this study were to estimate an upper bound for the proportion of men newly diagnosed with prostate cancer in Korea who could be managed with active surveillance (AS) when favorable intermediate-risk disease is included and to describe variation in AS eligibility by calendar year, administrative district, and residential setting. Materials and methods: We analyzed biopsy-confirmed prostate cancer diagnosed in 2010, 2012, 2014, 2016, 2018, and 2020 across 51 general hospitals nationwide. Risk was classified using routinely collected clinicopathologic variables (prostate-specific antigen, clinical T stage, Gleason grade group, and biopsy core involvement); AS eligibility was defined as the union of low risk, potentially low risk, and favorable intermediate risk. Group differences in proportions were evaluated using χ2 tests; temporal trend was assessed using a Cochran-Armitage trend test. Primary analyses used complete cases.
Results
Among 27,075 men (37.9% of nationally reported cases in the indexed years), 1,476 (5.45%) were low risk, 1,082 (4.00%) potentially low risk, 4,028 (14.88%) favorable intermediate risk, 5,880 (21.72%) unfavorable intermediate risk, and 14,609 (53.94%) high risk. Overall, 6,586 (24.3%) were AS-eligible. By year, AS eligibility decreased from 27.6% (2010) to 22.0% (2020) (p < 0.001). Across 17 districts, eligibility ranged from 16.9% (Chungbuk) to 29.3% (Gyeonggi) (p < 0.001). Urban areas (dong) had higher eligibility than rural areas (eup/myeon): 26.4% versus 20.5% (p < 0.001).
Conclusions
Approximately one-quarter of newly diagnosed men in Korea appear potentially eligible for AS under a maximized definition that includes favorable intermediate-risk disease. AS eligibility differed significantly by year, region, and residential setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, College of Medicine, Ewha Womans University, Mokdong Hospital, Seoul, Korea.
- Medical Research Center, College of Medicine, Yeungnam University, Daegu, Korea.
- Department of Statistics, Keimyung University, Daegu 42601, Korea.
Förderung
- Ministry of Science and ICT, South Korea
- Korea Health Industry Development Institute
- National Research Foundation of Korea
Zitieren
APA
Ko, Y. H., Kim, S. W., & Son, N. H. (2026). Active surveillance could apply to one-quarter of Korean prostate cancer cases: Insights from a 27,075-patient cohort. Prostate International, 14(2), 127-131. https://doi.org/10.1016/j.prnil.2025.12.004
Vancouver
Ko YH, Kim SW, Son NH. Active surveillance could apply to one-quarter of Korean prostate cancer cases: Insights from a 27,075-patient cohort. Prostate International. 2026;14(2):127-131. doi:10.1016/j.prnil.2025.12.004
BibTeX
@article{Ko2026,
author = {Ko, Young Hwii and Kim, Sang Won and Son, Nak-Hoon},
title = {Active surveillance could apply to one-quarter of Korean prostate cancer cases: Insights from a 27,075-patient cohort},
journal = {Prostate International},
year = {2026},
volume = {14},
number = {2},
pages = {127--131},
doi = {10.1016/j.prnil.2025.12.004}
}
EUVIMED